Even though respiratory viruses are one of the most common triggers for asthma exacerbations, not all of these viruses affect patients equally. There is no strong evidence supporting that patients with asthma have a higher risk of becoming seriously ill from coronavirus disease 2019 (CO-VID-19), although recent reports from the USA and the UK suggest that asthma is much more common in children and adults with mild to severe COVID-19 than has previously been reported in Asia and in Europe. As in previous severe acute respiratory syndrome (SARS) outbreaks, patients with asthma, especially children, appear to be less susceptible to the coronavirus with a low rate of asthma exacerbations. A different expression of viral receptors and T2 inflammation can be responsible for different outcomes. Future studies focused on asthma and on other allergic disorders are needed to provide a greater understanding of the impact of underlying asthma and allergic inflammation on COVID-19 susceptibility and disease severity. However, for the moment, it is crucial that asthmatic patients maintain their controller medication, from inhaled corticosteroids to biologics, without making any dose adjustments on their own or stopping the medication. New data are emerging daily, rapidly updating our understanding of this novel coronavirus.
Allergy; Asthma; COVID-19; Coronavirus disease 2019; Risk factors; T2 inflammation.
© 2020 S. Karger AG, Basel.
Treatment of COVID-19-exacerbated asthma: should systemic corticosteroids be used?
Am J Physiol Lung Cell Mol Physiol. 2020 Jun 1;318(6):L1244-L1247. doi: 10.1152/ajplung.00144.2020. Epub 2020 May 13.
Am J Physiol Lung Cell Mol Physiol. 2020.
COVID-19 and Asthma: Reflection During the Pandemic.
Clin Rev Allergy Immunol. 2020 May 28. doi: 10.1007/s12016-020-08797-3. Online ahead of print.
Clin Rev Allergy Immunol. 2020.
Features, Evaluation and Treatment Coronavirus (COVID-19).
2020 May 18. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–.
StatPearls. 2020 Jan–.
Free Books & Documents.
Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.
Lancet Psychiatry. 2020 May 18:S2215-0366(20)30203-0. doi: 10.1016/S2215-0366(20)30203-0. Online ahead of print.
Lancet Psychiatry. 2020.
Free PMC article.
Managing childhood allergies and immunodeficiencies during respiratory virus epidemics – The 2020 COVID-19 pandemic: A statement from the EAACI-section on pediatrics.
Pediatr Allergy Immunol. 2020 Apr 22:10.1111/pai.13262. doi: 10.1111/pai.13262. Online ahead of print.
Pediatr Allergy Immunol. 2020.
Free PMC article.